616196-26-0

Basic information

• Product Name: N-methoxy-3-(methoxymethoxy)-N-methylbenzamide
• Synonyms: N-methoxy-3-(methoxymethoxy)-N-methylbenzamide
• CAS NO: 616196-26-0
• Molecular Weight: 225.244
• Mol File: 616196-26-0.mol

Chemical Properties

• CAS DataBase Reference: N-methoxy-3-(methoxymethoxy)-N-methylbenzamide(CAS DataBase Reference)
• NIST Chemistry Reference: N-methoxy-3-(methoxymethoxy)-N-methylbenzamide(616196-26-0)
• EPA Substance Registry System: N-methoxy-3-(methoxymethoxy)-N-methylbenzamide(616196-26-0)

Safety Data

• Hazardous Substances Data: 616196-26-0(Hazardous Substances Data)

Upstream product

• 107-30-2 chloromethyl methyl ether 
• 615558-48-0 3-hydroxy-N-methoxy-N-methylbenzamide 
• 443893-70-7 ethyl 3-(methoxymethoxy)benzoate 
• 7781-98-8 ethyl-3-hydroxybenzoate 
• 6638-79-5 N,O-dimethylhydroxylamine*hydrochloride 
• 81245-43-4 3-(methoxymethoxy)benzoic acid 

Downstream Products

• 131481-04-4 1-(3-(methoxymethoxy)phenyl)propan-1-one 
• 1213256-36-0 (S)-1-azido-2-(3-(cyclobutylmethoxy)phenyl)butan-2-ol 
• 1213256-32-6 (S)-1-azido-2-(3-(tetrahydro-2H-pyran-4-yloxy)phenyl)butan-2-ol 
• 1384453-68-2 (S)-2-(3-(allyloxy)phenyl)-1-azidobutan-2-ol 
• 1213256-17-7 (S)-1-azido-2-(3-isobutoxyphenyl)butan-2-ol 
• 1350514-94-1 (S)-1-azido-2-(3-((1-methylcyclopropyl)methoxy)phenyl)butan-2-ol 
• 1213256-34-8 (S)-1-azido-2-(3-ethoxyphenyl)butan-2-ol 
• 1213256-23-5 (S)-1-azido-2-(3-(cyclopentyloxy)phenyl)butan-2-ol 
• 1384453-67-1 (R)-1-azido-2-(3-(cyclopropylmethoxy)phenyl)butan-2-ol 
• 1213256-24-6 (S)-1-azido-2-(3-(cyclopropylmethoxy)phenyl)butan-2-ol 
• 1384453-66-0 (S)-2-(3-(cyclobutylmethoxy)phenyl)butane-1,2-diol 
• 1384453-65-9 (S)-2-(3-(tetrahydro-2H-pyran-4-yloxy)phenyl)butane-1,2-diol 
• 1384453-64-8 (S)-2-(3-(allyloxy)phenyl)butane-1,2-diol 
• 1213256-12-2 (S)-2-(3-isobutoxyphenyl)butane-1,2-diol 

Relevant articles and documents

1,2,3-Triazole-containing uracil derivatives with excellent pharmacokinetics as a novel class of potent human deoxyuridine triphosphatase inhibitors

Deoxyuridine triphosphatase (dUTPase) has emerged as a potential target for drug development as a 5-fluorouracil-based combination chemotherapy. We describe the design and synthesis of a novel class of human dUTPase inhibitors, 1,2,3-triazole-containing u

2-(2,6-dichlorophenyl)-diarylimidazoles

The invention is directed to compounds of formula (I), which are valuable therapeutics for the treatment of cancer and related diseases.